Aviad Friedman - Director, Oramed Pharmaceuticals Inc

As of January 5, 2022


What is Aviad Friedman's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's Director, Aviad Friedman, is estimated to be about $59.92K . Aviad Friedman owns about 22,191 units of Oramed Pharmaceuticals Inc common stock. In the last 5 years at Oramed Pharmaceuticals Inc, Aviad Friedman has sold an estimated value of $0 worth.

What is Aviad Friedman's Past Insider Trading?

Aviad Friedman's largest purchase order was 2,500 units , worth over $12.37K on August 13, 2018. In total, Aviad Friedman has made about 5 transactions over 5 years of their time at Oramed Pharmaceuticals Inc. Aviad Friedman usually trades in January, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Aviad Friedman's' Mailing Address?

  • Mailing address is Hadassa 6 Tel Aviv L3 6451306 Israel

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on May 10, 2022 by Arie Mayer who sold 3,000 units worth $76.8K . In the last 13 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.22M and bought an estimated value of $6.11M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Miriam Kidron, Chief Scientific Officer,  Nadav Kidron, President and CEO,  and Leonard Sank, Director .

ORAMED PHARMACEUTICALS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1